These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37348559)

  • 1. Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease.
    Kim YC; Qi M; Dong X; Seok S; Sun H; Kemper B; Fu T; Kemper JK
    J Biol Chem; 2023 Aug; 299(8):104946. PubMed ID: 37348559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice.
    Huang Y; Chen H; Chen J; Wu Q; Zhang W; Li D; Lu Y; Chen Y
    Phytomedicine; 2024 Oct; 133():155919. PubMed ID: 39153277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial products linked to steatohepatitis are reduced by deletion of nuclear hormone receptor SHP in mice.
    Mifflin R; Park JE; Lee M; Jena PK; Wan YY; Barton HA; Aghayev M; Kasumov T; Lin L; Wang X; Novak R; Li F; Huang H; Shriver LP; Lee YK
    J Lipid Res; 2023 Dec; 64(12):100469. PubMed ID: 37922990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis
    Sun J; Fan J; Li T; Yan X; Jiang Y
    J Agric Food Chem; 2022 Sep; 70(38):12014-12028. PubMed ID: 36106619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.
    Seok S; Kanamaluru D; Xiao Z; Ryerson D; Choi SE; Suino-Powell K; Xu HE; Veenstra TD; Kemper JK
    J Biol Chem; 2013 Aug; 288(32):23252-63. PubMed ID: 23824184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
    Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
    J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigation of high-fat diet-induced hepatic steatosis by thyme (
    Sheng X; Zhan P; Wang P; He W; Tian H
    Food Funct; 2024 Jul; 15(14):7333-7347. PubMed ID: 38305590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
    Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
    Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
    Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
    Hernandez GV; Smith VA; Melnyk M; Burd MA; Sprayberry KA; Edwards MS; Peterson DG; Bennet DC; Fanter RK; Columbus DA; Steibel JP; Glanz H; Immoos C; Rice MS; Santiago-Rodriguez TM; Blank J; VanderKelen JJ; Kitts CL; Piccolo BD; La Frano MR; Burrin DG; Maj M; Manjarin R
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G582-G609. PubMed ID: 32003601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective FXR-SHP Regulation in Obesity Aberrantly Increases
    Seok S; Sun H; Kim YC; Kemper B; Kemper JK
    Diabetes; 2021 Mar; 70(3):733-744. PubMed ID: 33328206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice.
    Myronovych A; Salazar-Gonzalez RM; Ryan KK; Miles L; Zhang W; Jha P; Wang L; Setchell KD; Seeley RJ; Kohli R
    Obesity (Silver Spring); 2014 Nov; 22(11):2301-11. PubMed ID: 25376397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
    Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
    Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A.
    Kim YC; Seok S; Zhang Y; Ma J; Kong B; Guo G; Kemper B; Kemper JK
    Nat Commun; 2020 Nov; 11(1):5969. PubMed ID: 33235221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids.
    Janssen AWF; Houben T; Katiraei S; Dijk W; Boutens L; van der Bolt N; Wang Z; Brown JM; Hazen SL; Mandard S; Shiri-Sverdlov R; Kuipers F; Willems van Dijk K; Vervoort J; Stienstra R; Hooiveld GJEJ; Kersten S
    J Lipid Res; 2017 Jul; 58(7):1399-1416. PubMed ID: 28533304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.